Anna O.
- Country
- Spain
- Department
- Nephrology
Research Overview
- Evaluation of Baxdrostat on Ambulatory Blood Pressure in Patients with Resistant Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Baxdrostat in Patients with Uncontrolled and Resistant Hypertension on Multidrug Regimens: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 33 of 116 partner sites.
Specializations
Cardiovascular Research
This investigator specializes in studying resistant hypertension (rHTN), with particular focus on patients whose blood pressure remains elevated despite conventional treatments.
- Blood Pressure Management
- Treatment-Resistant Conditions
- Antihypertensive Therapy
The investigator's work explores therapeutic approaches for patients who do not respond adequately to standard multi-drug treatment regimens.
Clinical Assessment
Primary research interests include the evaluation of ambulatory blood pressure monitoring and its role in assessing treatment efficacy in cardiovascular conditions.
- 24-hour Blood Pressure Monitoring
- Systolic Blood Pressure Assessment
- Long-term Treatment Outcomes
The investigator focuses on comprehensive blood pressure assessment methodologies for patients with complex cardiovascular conditions.
Therapeutic Innovation
The investigator studies novel approaches to managing treatment-resistant hypertension, particularly focusing on emerging therapeutic options for challenging cases.
- Novel Therapeutic Compounds
- Multi-drug Treatment Strategies
- Complex Patient Care
Research efforts concentrate on advancing treatment options for patients who have exhausted conventional therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.